OKYO Pharma Limited ("OKYO" or the "Company") - Notice of Annual General Meeting
OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF) has announced its annual general meeting (AGM) scheduled for September 27, 2021, at 10:00 a.m. The notice and proxy form for the AGM will be sent to shareholders and made available on the company's website. This year, the meeting will be conducted virtually, allowing shareholders to attend and participate in the voting process. All voting will occur on a poll basis, and shareholders are encouraged to submit questions in advance. Full AGM details can be found in the Notice of AGM.
- Announcement of AGM on September 27, 2021, indicates ongoing corporate governance.
- Virtual meeting facilitates greater shareholder participation.
- None.
LONDON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that it will hold its annual general meeting ("AGM") on Monday 27 September 2021 at 10:00 a.m.
The Notice of AGM, together with a proxy form will be posted to shareholders today. The Notice of AGM will shortly also be available on the Company's website: www.okyopharma.com. As previously advised, the annual report and accounts for the Company can also be found at www.okyopharma.com.
Please note that arrangements for the AGM this year are for a virtual meeting using an electronic platform. All voting at the resolutions at the AGM will be conducted on a poll (a requirement of our articles of association) which means that you should submit your proxy (by post or, preferably, online voting) as soon as possible. We ask that, where possible, questions which shareholders wish to raise be submitted to info@okyopharma.com in advance.
The platform that we will be using will allow all shareholders to attend, ask questions on the day and have the option to submit a separate poll card at the electronic meeting but, to ease administration, we request that proxies be lodged in advance wherever possible.
Full details of the operation and arrangements for the AGM are set out in the Notice of AGM.
About OKYO Pharma Limited
OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the main market for listed securities of London Stock Exchange plc. OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.
Enquiries:
OKYO Pharma Limited Willy Simon +44 (0)20 7495 2379
For further information, please visit the Company's website at www.okyopharma.com.
FAQ
What is the date of OKYO Pharma's 2021 AGM?
Where can I find the notice for OKYO Pharma's AGM?
How will voting be conducted at the AGM?
What is the stock symbol for OKYO Pharma?
Will the AGM be in-person or virtual?
